These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8096070)

  • 21. [Extrapyramidal syndrome as a side-effect of treatment with thiethylperazine (torecan) and metoclopramide (Reglan) a review of ten cases (author's transl)].
    Babić K; Borcić D; Beus A
    Lijec Vjesn; 1977 Mar; 99(3):181-4. PubMed ID: 875594
    [No Abstract]   [Full Text] [Related]  

  • 22. [Extrapyramidal effects of antipsychotic drugs].
    Kulisevsky J; Otermin P
    Neurologia; 2003 Jun; 18(5):262-8. PubMed ID: 12768512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neurological symptoms in newborn infants due to the administration of psychopharmacologic agents during pregnancy].
    Garbis-Berkvens JM; Stricker BH; van der Zijden WA
    Ned Tijdschr Geneeskd; 1993 Sep; 137(37):1885-7. PubMed ID: 8105393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug-induced extrapyramidal syndrome. Apropos of 22 cases].
    López Rois F; Couce Pico M; Calvo Fernández J; Novo I; Castro-Gago M
    An Esp Pediatr; 1987 Feb; 26(2):91-3. PubMed ID: 3565961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Correction of an extrapyramidal neuroleptic syndrome with tryptophan and the dynamics of its concentration in the blood of patients].
    Balakleevskiĭ AI; Mitiukova TA; Vazhenin MM; Gaĭduk FM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):95-7. PubMed ID: 6112836
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of the methylxanthines, caffeine and theophylline, in the treatment of extrapyramidal disorders caused by treatment with neuroleptics. Development of a therapeutic hypothesis].
    Casas M; Torrens M; Duro P; Pinet C; Alvarez E; Udina C
    Encephale; 1989; 15 Spec No():177-80. PubMed ID: 2568253
    [No Abstract]   [Full Text] [Related]  

  • 27. [Extrapyramidal complications during treatment with chlorpromazine and reserpine: clinical and electromyographic study].
    Delay J; Deniker P; Bourguignon A; Lempérière T
    Vertex; 2005; 16(64):469-72. PubMed ID: 16314902
    [No Abstract]   [Full Text] [Related]  

  • 28. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models.
    Casey DE
    Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821
    [No Abstract]   [Full Text] [Related]  

  • 29. Reversal of morphine with naloxone precipitates haloperidol-induced extrapyramidal side effects.
    Guo SL; Lin CJ; Huang HH; Chen LK; Sun WZ
    J Pain Symptom Manage; 2006 May; 31(5):391-2. PubMed ID: 16716869
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antipsychotics use in drug abuse].
    Ochoa Mangado E
    Actas Esp Psiquiatr; 2001; 29(3):172-85. PubMed ID: 11412492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of novel antipsychotic drugs.
    Raleigh F
    Pharmacotherapy; 1996; 16(6 Pt 2):160S-165S; discussion 166S-168S. PubMed ID: 8948000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Extrapyramidal motor side-effects and blood profile changes. Stumbling blocks in psychiatric pharmacotherapy].
    Grohmann R; Hippius H; Rüther E
    MMW Fortschr Med; 2001 May; 143 Suppl 2():76-7. PubMed ID: 11434265
    [No Abstract]   [Full Text] [Related]  

  • 33. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
    Honer WG; Kopala LC; Rabinowitz J
    J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Extrapyramidal syndrome].
    Nakagawa S; Koyama T
    Ryoikibetsu Shokogun Shirizu; 2003; (38):179-82. PubMed ID: 12876960
    [No Abstract]   [Full Text] [Related]  

  • 35. Fluphenazine-induced extrapyramidal side effects in a horse.
    Brashier M
    Vet Clin North Am Equine Pract; 2006 Apr; 22(1):e37-45. PubMed ID: 16627093
    [No Abstract]   [Full Text] [Related]  

  • 36. Extrapyramidal syndrome presenting as dysphagia: a case report.
    Gonzalez F
    Am J Hosp Palliat Care; 2008; 25(5):398-400. PubMed ID: 19047493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute drug-induced extrapyramidal syndromes.
    De Silva KL; Muller PJ; Pearce J
    Practitioner; 1973 Sep; 211(263):316-20. PubMed ID: 4759239
    [No Abstract]   [Full Text] [Related]  

  • 38. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L; Casey DE; Hoffman WF; McCall AL
    Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders.
    Kim JH; Jung HY; Kang UG; Jeong SH; Ahn YM; Byun HJ; Ha KS; Kim YS
    Mov Disord; 2002 Nov; 17(6):1354-9. PubMed ID: 12465082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Extrapyramidal signs as side-effect with metoclopramid-medication (author's transl)].
    Tobolka-Christian G
    Padiatr Padol; 1978; 13(4):425-8. PubMed ID: 714491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.